| abstract |
The purpose of the present invention is to provide novel compounds having ACC2 selective inhibitory activity. In addition, the present invention provides a pharmaceutical composition comprising the compound. n A compound of Formula: n n n n n n n n n n or its pharmaceutically acceptable salt, n wherein, R 1 is substituted or unsubstituted fused aromatic heterocyclyl represented by Formula: n n n n n n n n n n n n n n wherein, n ring B is 5-membered ring, ring C is 6-membered ring; n n n ring A is substituted or unsubstituted non-aromatic carbocycle or the like; n —L 1 — is —O—(CR 6 R 7 )m— or the like; n —L 2 — is —O—(CR 6 R 7 )n— or the like; n each R 6 is independently hydrogen or the like; n each R 7 is independently hydrogen or the like; n each m is independently an integer of 0, 1, 2 or 3; n each n is independently an integer of 1, 2 or 3; n R 2 is substituted or unsubstituted alkyl; n R 3 is hydrogen or substituted or unsubstituted alkyl; n R 4 is substituted or unsubstituted alkylcarbonyl or the like. |